Anagrelide (Agrylin/Xagrid, Shire and Thromboreductin, AOP Orphan Pharmaceuticals AG) is a drug used for the treatment of essential thrombocytosis (also...
10 KB (877 words) - 22:57, 30 March 2024
those at high risk are treated with hydroxycarbamide, interferon-α or anagrelide). Currently unapproved but in late-stage clinical trials (NCT04254978)...
19 KB (2,159 words) - 09:04, 3 July 2024
platelet counts can be treated with hydroxyurea (a cytoreducing agent) or anagrelide (Agrylin). In Janus kinase 2 positive disorders, ruxolitinib (Jakafi)...
11 KB (1,066 words) - 01:55, 17 March 2024
thrombocythemia and polycythemia vera). It has been found to be superior to anagrelide for the control of ET. Sickle-cell disease (increases production of fetal...
20 KB (1,797 words) - 05:12, 10 July 2024
These drugs mimic sympathetic stimulation and increase cardiac output. Anagrelide Cilostazol is used in the treatment of intermittent claudication. Pimobendan...
22 KB (2,350 words) - 08:18, 3 June 2024
60-7550 Carbazeran EHNA Oxindole PDP PDE3 Adibendan Amrinone (inamrinone) Anagrelide Benafentrine Bucladesine Carbazeran Cilostamide Cilostazol Enoximone Imazodan...
200 KB (19,862 words) - 13:20, 18 July 2024
transformation to leukemia with this disorder. The primary treatment consists of anagrelide or hydroxyurea to lower platelet levels. Congenital amegakaryocytic thrombocytopenia...
16 KB (1,787 words) - 17:27, 22 February 2024
60-7550 Carbazeran EHNA Oxindole PDP PDE3 Adibendan Amrinone (inamrinone) Anagrelide Benafentrine Bucladesine Carbazeran Cilostamide Cilostazol Enoximone Imazodan...
82 KB (7,334 words) - 04:37, 1 July 2024
60-7550 Carbazeran EHNA Oxindole PDP PDE3 Adibendan Amrinone (inamrinone) Anagrelide Benafentrine Bucladesine Carbazeran Cilostamide Cilostazol Enoximone Imazodan...
36 KB (3,239 words) - 15:46, 31 May 2024
Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib...
34 KB (3,144 words) - 15:34, 1 July 2024
Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib...
31 KB (2,940 words) - 06:07, 28 February 2024
60-7550 Carbazeran EHNA Oxindole PDP PDE3 Adibendan Amrinone (inamrinone) Anagrelide Benafentrine Bucladesine Carbazeran Cilostamide Cilostazol Enoximone Imazodan...
22 KB (1,851 words) - 06:10, 8 March 2024
60-7550 Carbazeran EHNA Oxindole PDP PDE3 Adibendan Amrinone (inamrinone) Anagrelide Benafentrine Bucladesine Carbazeran Cilostamide Cilostazol Enoximone Imazodan...
24 KB (2,126 words) - 12:59, 18 July 2024
60-7550 Carbazeran EHNA Oxindole PDP PDE3 Adibendan Amrinone (inamrinone) Anagrelide Benafentrine Bucladesine Carbazeran Cilostamide Cilostazol Enoximone Imazodan...
14 KB (1,275 words) - 20:28, 8 July 2024
60-7550 Carbazeran EHNA Oxindole PDP PDE3 Adibendan Amrinone (inamrinone) Anagrelide Benafentrine Bucladesine Carbazeran Cilostamide Cilostazol Enoximone Imazodan...
8 KB (518 words) - 22:24, 7 January 2024
Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib...
61 KB (6,082 words) - 05:23, 17 June 2024
INN) Anacin-3 Anadrol-50 Anafranil anagestone (INN) anagliptin (INN) anagrelide (INN) Anaids Tablet anakinra (INN) Analpram-HC AnaMantle HC Anamine Syrup...
7 KB (420 words) - 06:24, 1 June 2024
Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib...
15 KB (1,438 words) - 02:57, 10 May 2024
Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib...
18 KB (1,554 words) - 00:17, 8 January 2024
Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib...
4 KB (411 words) - 21:05, 6 May 2024
Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib...
9 KB (716 words) - 04:40, 3 April 2024
60-7550 Carbazeran EHNA Oxindole PDP PDE3 Adibendan Amrinone (inamrinone) Anagrelide Benafentrine Bucladesine Carbazeran Cilostamide Cilostazol Enoximone Imazodan...
16 KB (1,721 words) - 04:09, 24 May 2024
60-7550 Carbazeran EHNA Oxindole PDP PDE3 Adibendan Amrinone (inamrinone) Anagrelide Benafentrine Bucladesine Carbazeran Cilostamide Cilostazol Enoximone Imazodan...
15 KB (1,520 words) - 03:03, 15 July 2024
Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib...
5 KB (210 words) - 06:16, 5 July 2024
Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib...
9 KB (595 words) - 19:48, 16 June 2024
60-7550 Carbazeran EHNA Oxindole PDP PDE3 Adibendan Amrinone (inamrinone) Anagrelide Benafentrine Bucladesine Carbazeran Cilostamide Cilostazol Enoximone Imazodan...
14 KB (718 words) - 14:56, 19 July 2024
Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib...
48 KB (4,385 words) - 13:38, 11 January 2024
Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib...
4 KB (128 words) - 11:38, 22 April 2024
60-7550 Carbazeran EHNA Oxindole PDP PDE3 Adibendan Amrinone (inamrinone) Anagrelide Benafentrine Bucladesine Carbazeran Cilostamide Cilostazol Enoximone Imazodan...
11 KB (942 words) - 05:41, 18 July 2024
60-7550 Carbazeran EHNA Oxindole PDP PDE3 Adibendan Amrinone (inamrinone) Anagrelide Benafentrine Bucladesine Carbazeran Cilostamide Cilostazol Enoximone Imazodan...
18 KB (1,886 words) - 15:58, 11 November 2023